XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
1. Basis of Presentation and Use of Estimates Organization, Consolidation and Presentation of Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 610,820 $ 676,844    
Cost of goods sold 284,854 314,427    
Deferred Revenue 70,800   $ 68,300  
Retained earnings 9,644,545   9,260,629  
Accumulated other comprehensive loss (425,971)   (336,038)  
Total stockholders' equity $ 9,051,134 9,763,716 8,741,133 $ 9,615,252
Revenue Allocation Percent To Lease Elements 3.00%      
Additional paid-in-capital $ 462,627   449,075  
Selling, general and administrative expense 214,883 225,553    
Research and Development Expense 66,375 74,951    
Interest expense 12,277 12,337    
Other Nonoperating Income (Expense) 34,516 50,431    
Deferred Revenue, Current 55,100   $ 51,100  
Europe [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 200,200 204,800    
Asia Pacific [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 117,200 135,800    
UNITED STATES        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales 252,900 297,000    
Americas [Member]        
Organization, Consolidation and Presentation of Financial Statements [Line Items]        
Net sales $ 40,500 $ 39,200